Displaying drugs 7026 - 7050 of 9783 in total
Odanacatib
Odanacatib is an inhibiter of cathepsin K which was originally developed be Merck & Co as a new treatment for osteoporosis . The drug made it to phase III trials before abandoned due to increased stroke.
Investigational
Domatinostat
Withdrawn
Elaidamide
Experimental
Valnoctamide
Valnoctamide has been used in trials studying the treatment of Mania and Schizoaffective Disorder, Manic Type.
Investigational
N-Methyl-N-(Methylbenzyl)Formamide
Experimental
SU9516
Experimental
Valrocemide
Investigational
CP1-1189
CPI-1189 has been used in trials studying the treatment of HIV Infections and AIDS Dementia Complex.
Investigational
AFN-1252
AFN-1252 has been used in trials studying the treatment of Cellulitis, Burn Infection, Wound Infection, Cutaneous Abscess, and Skin and Subcutaneous Tissue Bacterial Infections.
Investigational
Acetylcysteine amide
Experimental
Firolimogene autotemcel
Investigational
Displaying drugs 7026 - 7050 of 9783 in total